1-3 of 3
Henry C. Fung, M.D.
Close
Sort by
Journal Articles

The Role of FDG-PET in Hodgkin Lymphoma S/P Autologous Hematopoietic Cell Transplant (HCT) as a Predictor of Outcome.

Neel B. Shah, MD, Mohamed Farhat, M.D., Arti Lakhani, M.D., Daniel Mcfarland, D.O., Parameswaran Venugopal, M.D., Stephanie A Gregory, M.D., Jamile Shammo, M.D., John Maciejewski, M.D., Hande Tuncer, M.D., Henry C Fung, M.D.
Journal: Blood
Blood (2008) 112 (11): 2178.
https://doi.org/10.1182/blood.V112.11.2178.2178
Published: 2008
Journal Articles

A Prospective Study Evaluating the Safety and Efficacy of Combination Therapy with Fludarabine Plus Mitoxantrone Followed by Yttrium-90 ( 90 Y) Ibritumomab Tiuxetan (Zevalin®) and Maintenance Rituximab as Front Line Therapy for Patients with Intermediate or High Risk Follicular Non-Hodgkin’s Lymphoma.

Stephanie A. Gregory, MD, Mohamad Kassar, M.D., Henry C. Fung, M.D., Parameswaran Venugopal, M.D., Teresa M. O’Brien, Michelle Tenuto
Journal: Blood
Blood (2007) 110 (11): 1360.
https://doi.org/10.1182/blood.V110.11.1360.1360
Published: 2007
Journal Articles

90 Y-Ibritumomab Tiuxetan (Zevalin®) in Combination with High-Dose Therapy (HDT) Followed by Autologous Stem Cell Transplant (ASCT) May Improve Survival in Patients with Poor-Risk Follicular Lymphoma (FL) and Diffuse Large B-Cell Lymphoma (DLBCL): Results of a Retrospective Comparative Analysis.

Auayporn P. Nademanee, MD, Amrita Krishnan, M.D, Nicole Tsai, MS, MPH, Joycelynne Palmer, Ph.D., Arturo Molina, M.D., Henry C. Fung, M.D., David Yamauchi, M.D, Neil Martin Kogut, M.D., Stephen J. Forman, M.D., Andrew Raubitschek, M.D.
Journal: Blood
Blood (2006) 108 (11): 327.
https://doi.org/10.1182/blood.V108.11.327.327
Published: 2006